Margaret Malone, Ph.D.
Ph.D., University of Wales
Courses Taught at ACPHS
Clinical Nutrition Advanced Pharmacy Practice Experience
Outcome assessment in obesity, including changes in medication use, health-related quality of life assessment and factors influencing weight loss.
Alger-Mayer S. Polimeni J, Malone M. Pre-operative weight loss as a predictor of long term success following Roux-en-Y gastric bypass. Obesity Surgery 2008; 18 (7):772-5. DOI 10.1007s11695-008-9482-2.
Alger-Mayer S. Rosati C, Polimeni J, Malone M. Pre-operative binge eating status and gastric bypass surgery : a long term outcome study. Obesity Surgery 2009; 19:139-45. DOI 10.1007/s11695-008-9540-9.
Malone M, Alger-Mayer S, Polimeni JM. Antidepressant drug therapy does not affect weight loss one year after gastric bypass surgery. Obes Surg 2011. DOI 10.1007/s11695-010-0351-4. Published on line 1/14/11.
2011: Malone M, Polimeni JM, Alger-Mayer S. Health related quality of life up to four years after bariatric surgery. Obesity Society Annual Scientific Meeting, Orlando, FL.
2011: Malone M, Alger-Mayer S, Lindstrom J. Efficacy of Orlistat 60mg for recommended weight loss before bariatric surgery. Obesity Society Annual Scientific Meeting Orlando, FL.
2010: Malone M, Alger-Mayer S, Lindstrom J, Bailie GR. Iron deficiency and anemia after Roux-en-Y gastric bypass. Encore. ACCP Annual Meeting 2010, Austin, TX.
2010: Malone M, Alger-Mayer S, Lindstrom J, Bailie GR. Iron deficiency and anemia after Roux-en-Y gastric bypass. Society for the Advancement of Blood Management (SABM), 2010 Annual meeting, Puerto Rico.
2009: Malone M, Alger-Mayer S, Polimeni J. Do patients taking antidepressants have the same one year outcome after gastric bypass surgery? Obesity Society Annual Scientific Meeting 2009,Washington, DC.
Educational and Professional Affiliations
Fellow of the American College of Clinical Pharmacy
Fellow of the Royal Pharmaceutical Society of Great Britain
Fellow of the Obesity Society